FDA approves Pfizer’s maternal RSV vaccine despite trial safety signals of increased premature birth
A recent article published in The British Medical Journal (“The BMJ”) details the debate that has broken out over whether Pfizer should have told pregnant women participating in its trial of maternal […]
Read More